References
- Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(4):426–434. doi:10.1016/S0002-9394(14)70439-8.
- Thaller VT, Kaden K, Lane CM, Collin JR. Thyroid lid surgery. Eye (Lond). 1987;1(Pt 5)( (5)):609–614. doi:10.1038/eye.1987.94.
- Malhotra R, Selva D. Free tarsus autogenous graft struts for lower eyelid elevation. Ophthal Plast Reconstr Surg. 2005;21(2):117–122. doi:10.1097/01.IOP.0000155973.83411.28.
- Doxanas MT, Dryden RM. The use of sclera in the treatment of dysthyroid eyelid retraction. Ophthalmology. 1981;88(9):887–894. doi:10.1016/S0161-6420(81)80002-4.
- Sullivan SA, Dailey RA. Graft contraction: a comparison of acellular dermis versus hard palate mucosa in lower eyelid surgery. Ophthal Plast Reconstr Surg. 2003;19(1):14–24. doi:10.1097/01.IOP.0000040678.19893.F7.
- Kazim M, Gold KG. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease. Curr Opin Ophthalmol. 2011;22(5):391–393. doi:10.1097/ICU.0b013e3283499433.
- Levine MR, Chu A. Surgical treatment of thyroid-related lid retraction: a new variation. Ophthalmic Surg. 1991;22(2):90–94.
- Oestreicher JH, Pang NK, Liao W. Treatment of lower eyelid retraction by retractor release and posterior lamellar grafting: an analysis of 659 eyelids in 400 patients. Ophthal Plast Reconstr Surg. 2008;24(3):207–212. doi:10.1097/IOP.0b013e3181706840.
- Stephenson CM, Brown BZ. The use of tarsus as a free autogenous graft in eyelid surgery. Ophthal Plast Reconstr Surg. 1985;1(1):43–50. doi:10.1097/00002341-198501000-00007.
- Gardner TA, Kennerdell JS, Buerger GF. Treatment of dysthyroid lower lid retraction with autogenous tarsus transplants. Ophthal Plast Reconstr Surg. 1992;8(1):26–31. doi:10.1097/00002341-199203000-00004.
- Patel V, Osborne S, Morley AMS, Malhotra R. The use of pericranial flaps for reconstruction and elevation of the lower eyelid. Orbit. 2010;29(1):1–6. doi:10.3109/01676830903207794.
- Li TG, Shorr N, Goldberg RA. Comparison of the efficacy of hard palate grafts with acellular human dermis grafts in lower eyelid surgery. Plast Reconstr Surg. 2005;116(3):873–878 discussion879–80. doi:10.1097/01.prs.0000177694.39466.b2.
- Korn BS, Kikkawa DO, Cohen SR, Hartstein M, Annunziata CC. Treatment of lower eyelid malposition with dermis fat grafting. Ophthalmology. 2008;115(4):744–751.e2. doi:10.1016/j.ophtha.2007.06.039.
- Yoon MK, McCulley TJ. Autologous dermal grafts as posterior lamellar spacers in the management of lower eyelid retraction. Ophthal Plast Reconstr Surg. 2014;30(1):64–68. doi:10.1097/IOP.0000000000000012.
- Papakostas TD, Lee NG, Callahan AB, Freitag SK. Reactivation of thyroid associated orbitopathy following trauma with intraorbital foreign body. Orbit. 2015;34(1):6–9. doi:10.3109/01676830.2014.950301.
- Xu L, Glass LRD, Kazim M. Reactivation of thyroid eye disease following extraocular muscle surgery. Ophthal Plast Reconstr Surg. 2014;30(1):e5–e6. doi:10.1097/IOP.0b013e3182873cfe.
- Shadpour JM, Menghani RM, Douglas RS, Goldberg RA, Tsirbas A. Reactivation of thyroid-associated orbitopathy after cataract surgery. Jpn J Ophthalmol. 2009;53(1):44–46. doi:10.1007/s10384-008-0607-x.
- Strianese D, Piscopo R, Elefante A, et al. Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study. BMC Ophthalmol. 2013;13(1):21. doi:10.1186/1471-2415-13-21.
- Scruggs JT, McGwin G, Morgenstern KE. Use of noncadaveric human acellular dermal tissue (BellaDerm) in lower eyelid retraction repair. Ophthal Plast Reconstr Surg. 2015;31(5):379–384. doi:10.1097/IOP.0000000000000353.
- Campbell DG, Li P. Sterilization of HIV with irradiation: relevance to infected bone allografts. Aust N Z J Surg. 1999;69(7):517–521. doi:10.1046/j.1440-1622.1999.01615.x.
- Marx RE, Carlson ER. Creutzfeldt-Jakob disease from allogeneic dura: a review of risks and safety. J Oral Maxillofac Surg. 1991;49(3):272–274 discussion274–5. doi:10.1016/0278-2391(91)90218-B.
- Liao SL, Wei YH. Correction of lower lid retraction using tarSys bioengineered grafts for graves ophthalmopathy. Am J Ophthalmol. 2013;156(2):387–392.e1. doi:10.1016/j.ajo.2013.03.017.
- Lee YJ, Khwarg SI. Polytetrafluoroethylene as a spacer graft for the correction of lower eyelid retraction. Korean J Ophthalmol. 2005;19(4):247–251. doi:10.3341/kjo.2005.19.4.247.
- Nava Castañeda A, Tovilla Canales JL, Garnica Hayashi L, Velasco Y, Levy A. Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A. J Fr Ophtalmol. 2017;40(4):279–284. doi:10.1016/j.jfo.2016.10.016.
- Strianese D. Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease. Curr Opin Ophthalmol. 2017;28(5):505–513. doi:10.1097/ICU.0000000000000402.
- Uccello G, Vassallo P, Strianese D, Bonavolonta G. Free levator complex recession in Graves’ ophthalmopathy our experience. Orbit. 2009;13(3):119–123. doi:10.3109/01676839409031146.